Literature DB >> 3511343

The disease of Emperor Frederick III.

B Minnigerode.   

Abstract

The disease and death of German Emperor Frederick III has often been described in historical and medical treaties. These were all based on official political and medical reports published during 1887-1888, the time of the disease. The assertion of laryngologists, made while Frederick III was still alive, that the laryngeal carcinoma developed from a specific syphilitic infection is examined here. On the basis of the relevant laryngological literature, as well as less well-known sources, the probability of this assumption, the particular symptoms, and the fulminant course of the disease are documented. The behavior and the personality of Sir Morell Mackenzie is accordingly seen in a different light than in the past.

Entities:  

Mesh:

Year:  1986        PMID: 3511343     DOI: 10.1288/00005537-198602000-00014

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  5 in total

Review 1.  [Reconstruction of the examination of the laryngeal carcinoma of Emperor Frederick III by Rudolf Virchow].

Authors:  K Hussein; B Panning
Journal:  Pathologe       Date:  2018-03       Impact factor: 1.011

2.  The laryngeal disease of the German Emperor Friedrich III: treatment failure or fateful course.

Authors:  Heinrich Rudert; Jochen A Werner
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-19       Impact factor: 2.503

Review 3.  Molecular Targets and Therapeutic Strategies in Spinocerebellar Ataxia Type 7.

Authors:  Anna Niewiadomska-Cimicka; Yvon Trottier
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

4.  Tracheostomy.

Authors:  A L Pahor
Journal:  J R Soc Med       Date:  1993-05       Impact factor: 18.000

Review 5.  125 years of head and neck radiotherapy: could organ-sparing radiotherapy of larynx cancer have prevented World War I?

Authors:  Thomas B Brunner; Herbert Wördehoff; Ahmed Gawish; Uwe Busch
Journal:  Strahlenther Onkol       Date:  2022-02-11       Impact factor: 3.621

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.